Skip to content

Regenerating lost jaw bone using patient specific 3D-printed resorbable polycaprolactone mesh versus a resorbable collagen membrane

A randomized controlled clinical trial evaluating the efficacy of a patient specific 3D-printed resorbable polycaprolactone mesh versus a resorbable collagen barrier membrane in guided bone regeneration

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000122459
Enrollment
3
Registered
2025-02-03
Start date
2025-03-06
Completion date
2026-12-31
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The objective of this randomized controlled clinical trial is to compare the efficacy of a patient specific 3D-printed manufactured medical grade polycaprolactone mesh with a collagen membrane that are loaded with particulate anorganic porcine bone mineral and autogenous bone in the reconstruction of alveolar ridge defects. Lay public hypothesis: We anticipate no significant differences when using customized 3D-printed polymer (polycaprolactone) mesh or the current technique of using animal derived collagen membranes trimmed chair-side to reconstruct lost jaw bone. The trial will report results for a extensive range of outcomes including; graft volume, post-operative recovery/morbidity, implant feasibility, histology, peri-implant parameters and patient reported outcomes

Interventions

The trial compare effectiveness of the using a 3D printed patient specific polycaprolactone (PCL) (test) mesh versus a collagen membrane (control) when combined with a a composite graft composed of particulate anorganic porcine bone mineral (APBM) and autogenous bone (AB) in a 1:1 ratio for alveolar ridge augmentation (replacing lost jaw bone). What occurs during these interventions: There are two surgical interventions. The first is alveolar ridge augmentation, which is performed to reconstr

The trial compare effectiveness of the using a 3D printed patient specific polycaprolactone (PCL) (test) mesh versus a collagen membrane (control) when combined with a a composite graft composed of particulate anorganic porcine bone mineral (APBM) and autogenous bone (AB) in a 1:1 ratio for alveolar ridge augmentation (replacing lost jaw bone). What occurs during these interventions: There are two surgical interventions. The first is alveolar ridge augmentation, which is performed to reconstruct the lost jaw bone required for dental implant placement. This surgery will be performed by experienced specialist clinicians (Periodontists) with more than 17 years experience in complex alveolar bone reconstructive surgery. The procedure involves achieving access to the bone defect via a mucoperiosteal flap. Autogenous bone harvesting is performed from the retro-molar region and mixed with porcine bone mineral then loaded into the defect and covered using a patient specific 3D printed polymer (PCL) scaffold (test group) or a collagen membrane (control). This is secured to the jaw bone then covered by the flap. Surgery will be performed in a private practice and will be 90-120min in duration. The second intervention takes place 8 months later, and takes approximately 1 hour to complete. It involves elevating a mucoperiosteal flap then creating an osteotomy of specific dimensions to allow the placement of the dental implant. The flap is then replaced and allowed to heal for a further 12 weeks before the patient continues the prosthetic phase of treatment with their referring clinicians independent of the study. Adherence to intervention will be assessed by reviewing completed case report forms (CRFs).

Sponsors

University of Queensland
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Individuals aged between 18 and 65 years, medically healthy or with mild controlled systemic disease, able to undergo oral surgical procedures under local or general anaesthesia 2. Adequate plaque control (FM plaque and BOP scores less than or equal to 25%) at study baseline 3. Dental implant placement replacing 1-4 teeth in a partially dentate patient 4. Horizontal alveolar ridge deficiency preventing dental implant placement in a prosthetically driven position or with an unstable defect morphology necessitating staged bone augmentation (class-3, 4) 5. If bilateral ridge augmentation is required, only one ridge will be randomly selected and used for the purposes of this study 6. Teeth at the surgical site which require removal are extracted a minimum of 12 weeks prior to ridge augmentation 7. Adequate soft tissue profile for staged ridge augmentation. This includes a minimum zone of 2mm of keratinized gingival tissue at the buccal aspect of the surgical zone and adequate tissue thickness. Thickness is assessed by transparency of periodontal probe through the gingival margin of the adjacent teeth. Inadequate tissue parameters can be repaired prior to trial participation. 8. Treated and stable periodontal disease as assessed by specialist Periodontists with stability defined as having a full mouth bleeding score of less than or equal to 20% and no sites of residual periodontal probing depth less than or equal to 5mm

Exclusion criteria

1. Pregnancy at the time of recruitment 2. Alcoholism or chronic drug abuse 3. Patients who smoke more than 10 cigarettes per day 4. Medications or pathology which interferes with bone formation 5. History of local radiation therapy 6. Severe parafunction 7. Extensive metallic restorations in region of interest especially post-core restorations 8. Presence of dental implant adjacent to region of interest 9. Oral mucosal disease such as Lichen Planus

Outcome results

None listed

Source: ANZCTR · Data processed: Jun 21, 2026